RHI Magnesita H1 2025 Profit Slumps 26% Amid Industrial Project Deferrals

The Numbers Tell the Story: A Sharp H1 Contraction

RHI Magnesita’s H1 2025 results landed with a thud, painting a clear picture of the significant headwinds facing the global refractory leader. Adjusted EBITA slumped 26% year-on-year to €141 million, while revenue dipped 3% to €1,677 million. The adjusted EBITA margin compressed sharply to 8.4% from 11.0% in H1 2024. Driving this decline was a perfect storm:

• Industrial Project Carnage: Deferrals hit hard, with Glass project revenue down 40% and Non-ferrous Metals projects down 22%. Customers pressed pause on major investments.
• Pricing Under Siege: Aggressive competition, particularly from Chinese exporters and local players in key growth markets like India, China, East Asia, and META, drove a 5% decline in average prices. Customers opted for cheaper, lower-performance products.
• Cost Pressures Mounting: Low plant utilisation hurt fixed cost absorption, while wage inflation, stubbornly high alumina-based raw material costs (despite a recent dip), and elevated natural gas prices squeezed margins.
• Mix Shift Woes: Industrial sales skewed towards lower-margin Cement segment work and repair jobs, rather than higher-value project business.

The result? Gross margin tumbled to 20.8% from 24.1%. Adjusted EPS nearly halved, dropping 47% to €1.37. Cash flow held relatively resilient (Adjusted Operating Cash Flow €175m, down 21%), but net debt ballooned 24% to €1,583m (Net Debt/Pro Forma EBITDA 3.1x), largely due to the Resco acquisition.

Management’s Counter-Punch: Banking on H2

Facing these challenges head-on, CEO Stefan Borgas and his team haven’t been idle. They’ve outlined a clear action plan targeting a significant H2 rebound, projecting up to €120 million of Adjusted EBITA uplift net of FX headwinds:

• Project Deliveries: €50m expected from the phasing of the Non-ferrous Metals order book, including those H1 deferrals.
• Price Leadership: €30m targeted from a selective price increase programme, primarily in the Steel business.
• Volume & Efficiency: €20m from higher Steel volumes (relying on order book strength and typical H2 seasonality) and €10m from plant efficiency/fixed cost initiatives.
• Cost Cutting Bites: €10m incremental SG&A savings (€20m annualised) and €10m from executed plant closures in Germany (Wetro, Mainzlar).
• Synergy Harvest: €10m from Resco integration ramp-up and a full six-month contribution.

This plan is ambitious but necessary. It acknowledges the fierce competitive landscape while leveraging RHI Magnesita’s operational levers and order book visibility.

Revised Guidance & The Elephant in the Room: Debt

Reflecting the weaker-than-expected H1 and incorporating the expected FX drag (a potential €10m H2 headwind), management has materially downgraded full-year expectations. Adjusted EBITA is now guided to €370-390 million (constant currency €380-400m), implying an average margin of 10.5-11.0%. This is a significant step down from the pre-announcement analyst consensus of €406 million.

Capital expenditure has been prudently trimmed (€145m to €130m), and working capital intensity (c.24%) remains a focus. The maintained interim dividend of €0.60 per share signals confidence in the medium-term strategy and cash generation, but it’s the debt position that grabs attention.

The Resco acquisition has pushed Net Debt/Pro Forma Adjusted EBITDA to 3.1x, well above the company’s stated target range of 1.0-2.0x through the cycle (or up to 2.5x for compelling M&A). Management expects gearing to reduce to ~2.8x by year-end and further into 2026. This elevated leverage is the unavoidable consequence of the aggressive M&A-led consolidation strategy in a cyclical downturn. While the strategy has merit long-term, it undeniably increases financial risk in the near term, especially if the H2 recovery falters.

Operational & Regional Nuances: Not All Gloom

Digging deeper reveals a mixed regional picture:

• North America (Up 18%): The Resco acquisition provided a significant boost (€90m revenue). The base business dipped slightly (-4%), but integration is progressing, and the new US recycling JV with BPI offers future promise. Steel demand was stable, though tariffs pose a complex risk/reward dynamic.
• Europe & CIS (Down 10%): The hardest hit region, suffering from structural steel decline (-11.6% in Germany!), project deferrals, weak Glass markets, and tariff impacts. Plant closures (Wetro, Mainzlar) are a direct response to overcapacity. Recycling rates shone (22.5%).
• India (Flat Revenue, But Margins Crushed): Volumes grew 7%, but ferocious price competition (from imports and domestic players) caused a 7% drop in average prices and a 40% plunge in gross profit. Margins collapsed to 12.7% (from 21.0%). New steel tariffs offer some hope.
• Latin America (Down 14%), China & East Asia (Down 5%), META (Down 15%): All faced volume declines, pricing pressure, and specific regional challenges (import competition, weak construction, FX).

Strategically, the Resco integration and network optimisation remain central. The closure of two German plants is just the start of addressing structural overcapacity, particularly in Europe.

Steel vs. Industrial: A Tale of Two Divisions

The split between the core Steel business (68% of revenue) and Industrial (32%) was stark:

• Steel: Revenue down 3%, Adjusted EBITA down 19%. Volumes ex-M&A down 1%, pricing down 5%. Characterised as “low but stable” demand, with regional divergence (India/NAM growth vs. Europe decline). The battleground is price in commoditised segments.
• Industrial: Revenue down 2%, but Adjusted EBITA plummeted 36%. The double whammy of project deferrals (especially Non-ferrous Metals & Glass) and a mix shift to lower-margin Cement/repair work devastated profitability. Cement showed some resilience (+5% revenue).

The H2 recovery hinges heavily on the anticipated rebound in Industrial project execution.

Conclusion: Navigating Turbulence with a Clear, if Risky, Compass

RHI Magnesita’s H1 was undeniably tough. Industrial project deferrals, intense price competition, and cost pressures combined to deliver a sharp profit decline. The balance sheet is stretched following the Resco deal. Management’s response is robust – a detailed €120m H2 uplift plan combining project delivery, price action, cost cuts, and synergies. The revised €370-390m FY guidance reflects both the H1 miss and ongoing FX headwinds.

The maintained dividend offers shareholder reassurance, but the elevated debt (3.1x) is the key watchpoint. Execution of the H2 plan is paramount to start deleveraging. While the near-term outlook remains challenging, particularly in Europe and amidst global trade tensions, the long-term M&A-led consolidation strategy in a fragmented market still holds logic. However, investors will need patience and a strong stomach for volatility. The next six months are critical for proving the resilience of the model and the efficacy of management’s countermeasures.